Ardent Health Partners (NYSE:ARDT) Sets New 52-Week Low – Should You Sell?

Ardent Health Partners, LLC (NYSE:ARDT)’s stock price hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $14.00 and last traded at $14.05, with a volume of 656358 shares changing hands. The stock had previously closed at $16.05.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Stephens reissued an “overweight” rating and set a $24.00 target price on shares of Ardent Health Partners in a research report on Thursday, September 19th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $20.00 price objective on shares of Ardent Health Partners in a research report on Tuesday, December 17th. KeyCorp initiated coverage on Ardent Health Partners in a research report on Friday, October 11th. They set an “overweight” rating and a $24.00 target price on the stock. Leerink Partners raised their price objective on Ardent Health Partners from $23.00 to $25.00 and gave the company an “outperform” rating in a research note on Tuesday, November 12th. Finally, Truist Financial cut their target price on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Two equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $22.00.

Ardent Health Partners Stock Performance

The business has a 50 day simple moving average of $16.45. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. BNP Paribas Financial Markets bought a new position in shares of Ardent Health Partners during the third quarter valued at approximately $42,000. Financial Management Professionals Inc. bought a new stake in shares of Ardent Health Partners in the 3rd quarter worth approximately $50,000. MetLife Investment Management LLC acquired a new position in Ardent Health Partners during the 3rd quarter valued at approximately $135,000. JPMorgan Chase & Co. bought a new position in Ardent Health Partners during the 3rd quarter worth $154,000. Finally, Quadrature Capital Ltd acquired a new stake in Ardent Health Partners in the third quarter worth $229,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.